ANGPT1 and breast carcinoma: There were no significant changes in the plasma concentration of Ang-1 (Figure 4A), while plasma Ang-2 concentration and soluble form of Tie-2 receptor for angiopoetins were both increased by dabigatran treatment 2 days after the injection of breast cancer cells compared to untreated mice (Figure 4B).